Nyheter

Nyheter

iCellate has been voted an organizational member of NACG

iCellate is pleased to announce that we has been voted an organizational member of NACG, the Nordic Alliance for Clinical Genomics.

Nyheter

iCellate is disrupting cancer care. Join us!

We now recruit for 3 new positions!

Nyheter

iCellate and Elthera consortium awarded with Eurostars grant of 25 MSEK for companion diagnostic development

Nyheter

iCellate has been selected by Novartis to participate in their Techcare program

Nyheter

iCellate hires - 3 new positions!

Come and join the iCellate team!

Nyheter

iCellate välkomnar sin nya R&D-chef Åsa Rosenquist

Nyheter

Brinner du för laboratoriearbete i allmänhet och mikroskopering i synnerhet?

Vi erbjuder en spännande arbetsmiljö i ett växande bolag där vi hoppas att du vill vara med och göra skillnad, inte bara hos oss utan även i…

Nyheter

Stockholmsbolag redo att revolutionera cancervården

I dag lanserar iCellate Medical en tjänst som ska hjälpa läkare att sätta in rätt behandling för diagnostiserade cancerpatienter.

Nyheter

iCellate is hiring an R&D Director

We are looking for a new R&D Director

Nyheter

Two new colleagues

Welcome Bonoshree and Sofia!

Nyheter

iCellate Medical raises 16 MSEK in new equity to demonstrate its clinical validity and utility

Nyheter

New board appointed at extraordinary general meeting

Nyheter

Building for the future

New lab and office space in Hagalund

Nyheter

iCellate signs contract for new facility

Nyheter

iCellate Medical closes 15 million SEK second round of funding

Nyheter

IsoPic gets CE-approval

Nyheter

Pelle Redare, CEO, speaks at Karolinska Institute Science Park Day

Nyheter

iCellate Medical initiates a genetic sequencing project to further understand the causes of cancer

Nyheter

iCellate forms a team for the future

Nyheter

New grant: BIO-X support from Uppsala BIO